BHVN peer analysis
Biohaven (BHVN) against its competitors: price, today's move, 1-year return and market value side by side.
- BHVN's peers: ABCL (AbCellera), CLDX (Celldex Therapeutics), IMCR (Immunocore), IMNM (Immunome), NTLA (Intellia), PHVS (Pharvaris), SION (Sionna Therapeutics), VERA (Vera Therapeutics).
BHVN and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ABCL AbCellera | $9.73 | -7.07% | 169.53% | $3.18B |
| CLDX Celldex Therapeutics | $27.40 | -2.00% | 9.95% | $2.15B |
| IMCR Immunocore | $26.41 | -0.83% | -31.67% | $1.36B |
| IMNM Immunome | $15.69 | -5.54% | -11.31% | $1.85B |
| NTLA Intellia | $10.00 | 5.05% | 21.37% | $1.40B |
| PHVS Pharvaris | $31.28 | -1.20% | 27.47% | $2.21B |
| SION Sionna Therapeutics | $2.88 | -3.03% | -92.50% | $130.28M |
| VERA Vera Therapeutics | $24.88 | -6.99% | -12.86% | $1.80B |
| XERS Xeris Biopharma | $17.00 | 2.29% | 139.77% | $3.11B |
| ZBIO Zenas BioPharma | $23.00 | -8.15% | -38.09% | $1.56B |
| BHVN Biohaven | $12.51 | -8.35% | 32.24% | $1.89B |